Wells Fargo
RVMD icon

Wells Fargo’s Revolution Medicines RVMD Stock Holding History

Wells Fargo’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,400
Closed -$510K – 7422
2025
Q4 		$510K Hold
6,400
– – ﹤0.01% 4484
2025
Q3 		$299K Hold
6,400
– – ﹤0.01% 4688
2025
Q2 		$235K Buy
+6,400
New +$246K ﹤0.01% 4680

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wells Fargo's RVMD Position: Q2 2026 in Review

Wells Fargo increased its Revolution Medicines (RVMD) stake by 422% in Q2 2026, buying an estimated $21.1M and bringing the position to 178,780 shares worth $33.5M. The position accounts for 0.01% of the portfolio, ranked #1287.

Wells Fargo first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Wells Fargo held 178,780 shares of Revolution Medicines worth $33.5M as of Q2 2026.
  • Wells Fargo bought 144,539 Revolution Medicines shares in Q2 2026, an estimated $21.1M.
  • Revolution Medicines made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #1287 holding.
  • Wells Fargo first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.